Abstract:Background Genomic surveillance has shaped our understanding of SARS-CoV-2 variants, which have proliferated globally in 2021. Characterizing global genomic surveillance, sequencing coverage, the extent of publicly available genomic data coupled with traditional epidemiologic data can provide evidence to inform SARS-CoV-2 surveillance and control strategies. Methods We collected country-specific data on SARS-CoV-2 genomic surveillance, sequencing capabilities, public genomic data, and aggregated publicly available variant data. We divided countries into three levels of genomic surveillance and sequencing availability based on predefined criteria. We downloaded the merged and deduplicated SARS-CoV-2 sequences from multiple public repositories, and used different proxies to estimate the sequencing coverage and public availability extent of genomic data, in addition to describing the global dissemination of variants. Findings Since the start of 2021, the COVID-19 global epidemic clearly featured increasing circulation of Alpha, which was rapidly replaced by the Delta variant starting around May 2021 and reaching a global prevalence of 96.6% at the end of July 2021. SARS-CoV-2 genomic surveillance and sequencing availability varied markedly across countries, with 63 countries performing routine genomic surveillance and 79 countries with high availability of SARS-CoV-2 sequencing. Less than 3.5% of confirmed SARS-CoV-2 infections were sequenced globally since September 2020, with the lowest sequencing coverage in the WHO regions of Eastern Mediterranean, South East Asia, and Africa. Across different variants, 28-52% of countries with explicit reporting on variants shared less than half of their variant sequences in public repositories. More than 60% of demographic and 95% of clinical data were absent in GISAID metadata accompanying sequences. Interpretation Our findings indicated an urgent need to expand sequencing capacity of virus isolates, enhance the sharing of sequences, the standardization of metadata files, and supportive networks for countries with no sequencing capability.

Global genomic diversity and conservation of SARS-CoV-2 since the COVID-19 outbreak

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective

Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China

Emergence of genomic diversity and recurrent mutations in SARS-CoV-2

The emergence, genomic diversity and global spread of SARS-CoV-2

Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19

On the Origin and Continuing Evolution of SARS-CoV-2

Structural Genomic Analysis of SARS-CoV-2 and Other Coronaviruses

Genotyping coronavirus SARS-CoV-2: methods and implications

Genome-wide Mutation Landscape of SARS-CoV-2

The Discovery of Gene Mutations Making SARS-CoV-2 Well Adapted for Humans: Host-Genome Similarity Analysis of 2594 Genomes from China, the USA and Europe

Evolution and Variation of the SARS-CoV Genome

Genome-wide data inferring the evolution and population demography of the novel pneumonia coronavirus (SARS-CoV-2)

Discovering SARS-CoV-2 Genes and Mutations Adapted for Humans in 2594 Genomes

Genomic Epidemiology of Imported Cases of COVID-19 in Guangdong Province,China,October 2020–May 2021

Evolutionary Dynamics of the Severe Acute Respiratory Syndrome Coronavirus 2 Genomes

Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome

Snapshot of the Evolution and Mutation Patterns of SARS-CoV-2.

Worldwide tracing of mutations and the evolutionary dynamics of SARS CoV 2

Landscape of SARS-CoV-2 genomic surveillance, public availability extent of genomic data, and epidemic shaped by variants: a global descriptive study